T
Tong Liu
Researcher at Tianjin Medical University
Publications - 610
Citations - 8658
Tong Liu is an academic researcher from Tianjin Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 35, co-authored 461 publications receiving 5460 citations. Previous affiliations of Tong Liu include Rutgers University & Medical College of Wisconsin.
Papers
More filters
Journal ArticleDOI
Animal models of atherosclerosis (Review)
Yee Ting Lee,Victoria Laxton,Hiu Yu Lin,Yin Wah Fiona Chan,Sophia Fitzgerald‑Smith,Tsz Ling Olivia To,Bryan P. Yan,Tong Liu,Gary Tse +8 more
TL;DR: Different species of atherosclerosis models are outlined, with discussions on the practicality of their use for experimentation, and their advantages and disadvantages.
Journal ArticleDOI
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
Yutao Guo,Hao Wang,Hui Zhang,Tong Liu,Zhaoguang Liang,Yunlong Xia,Li Yan,Yunli Xing,Haili Shi,Shuyan Li,Yanxia Liu,Fan Liu,Mei Feng,Yundai Chen,Gregory Y.H. Lip,Mafa Ii Investigators +15 more
TL;DR: Continuous home monitoring with smart device–based PPG technology could be a feasible approach for AF screening and detection, as well as early interventions to reduce stroke and other AF-related complications.
Journal ArticleDOI
Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation
Yutao Guo,Deirdre A. Lane,Limin Wang,Hui Zhang,Hao Wang,Wei Zhang,Jing Wen,Yunli Xing,Fang Wu,Yunlong Xia,Tong Liu,Fan Wu,Zhaoguang Liang,Fan Liu,Yujie Zhao,Rong Li,Xin Li,Lili Zhang,Jun Guo,Girvan Burnside,Yundai Chen,Gregory Y.H. Lip,mAF-App Ii Trial investigators +22 more
TL;DR: An integrated care approach to holistic AF care, supported by mHealth technology, reduces the risks of rehospitalization and clinical adverse events.
Journal ArticleDOI
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats.
Qingmiao Shao,Lei Meng,Sharen Lee,Gary Tse,Mengqi Gong,Zhiwei Zhang,Jichao Zhao,Yungang Zhao,Guangping Li,Tong Liu +9 more
TL;DR: Empagliflozin can ameliorate atrial structural and electrical remodeling as well as improve mitochondrial function and mitochondrial biogenesis in T2DM, hence may be potentially used in the prevention of T2 DM-related atrial fibrillation.
Journal ArticleDOI
Correlating microbial community compositions with environmental factors in activated sludge from four full-scale municipal wastewater treatment plants in Shanghai, China.
TL;DR: Alternative operation methods including a fluctuation of anoxic, oxic, and anaerobic conditions were favorable for promoting the growth of diverse microbial populations in activated sludge systems.